1. Home
  2. BCH vs MEDP Comparison

BCH vs MEDP Comparison

Compare BCH & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCH

Banco De Chile ADS

HOLD

Current Price

$37.17

Market Cap

15.0B

Sector

Finance

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$543.83

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCH
MEDP
Founded
1893
1992
Country
Chile
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
13.4B
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
BCH
MEDP
Price
$37.17
$543.83
Analyst Decision
Hold
Hold
Analyst Count
2
12
Target Price
$28.00
$465.18
AVG Volume (30 Days)
315.9K
277.0K
Earning Date
10-30-2025
10-22-2025
Dividend Yield
4.23%
N/A
EPS Growth
N/A
25.36
EPS
0.01
14.32
Revenue
$2,793,481,720.00
$2,358,373,000.00
Revenue This Year
$17.92
$21.48
Revenue Next Year
$6.34
$11.90
P/E Ratio
$15.02
$38.28
Revenue Growth
N/A
13.88
52 Week Low
$22.06
$250.05
52 Week High
$38.73
$626.26

Technical Indicators

Market Signals
Indicator
BCH
MEDP
Relative Strength Index (RSI) 56.32 36.48
Support Level $37.82 $530.96
Resistance Level $38.66 $626.26
Average True Range (ATR) 0.67 18.24
MACD -0.08 -8.14
Stochastic Oscillator 36.80 17.60

Price Performance

Historical Comparison
BCH
MEDP

About BCH Banco De Chile ADS

Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: